注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
逸达生物科技股份有限公司是一家主要从事新型药物的研究与开发的台湾公司。该公司的主要产品包括前列腺癌治疗产品FP-001和哮喘/慢性阻塞性肺病治疗产品FP-025。该公司还从事新型药物临床试验业务。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Fu-Shiow Yin | - | 2016 | Independent Director |
Daria Mochly-Rosen | - | - | Member of Scientific Advisory Board |
Joseph P. Vacca | - | - | Member of Scientific Advisory Board |
Benjamin Chien | - | 2013 | Founder, CEO & Chairman |
Eric M. Gordon | - | - | Member of Scientific Advisory Board |
Wen-Chi Lee | - | 2016 | Independent Director |
Luo Ming Ling | - | 2015 | Supervisor |
Jia-Long Lee | - | 2015 | Director |
Jeff Wang | - | 2016 | Director |
Vincent Yen | - | 2013 | Representative Director |
Hank Lai | - | 2018 | Independent Director |
Ben Liu | - | 2023 | Independent Director |
Yisheng Lee | - | 2013 | Chief Medical Officer, Acting Head of Clinical Development & Representative Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核